Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

A novel device that employs TTF therapy has recently been developed and is currently in use for the treatment of recurrent glioblastoma (rGBM). It was FDA approved in April 2011 for the treatment of patients 22 years or older with rGBM. The device delivers alternating electric fields and is programm...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Visualized Experiments 2014-10 (92), p.e51638-e51638
1. Verfasser:	Omar, Ayman I.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Brain Neoplasms - drug therapy Brain Neoplasms - therapy Combined Modality Therapy Electric Stimulation Therapy - methods Female Glioblastoma - drug therapy Glioblastoma - therapy Humans Medicine Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - therapy
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!